The PubMed entry describes a multicenter, population-based study titled “Impact of ABO Blood System on Immunogenicity and Vaccine Efficacy of COVID-19 Booster Vaccination—A Population-Based Study of 3066 Individuals.” The record identifies the work as published in Influenza and Other Respiratory Viruses (2026 Aug;20(8):e70300) with DOI 10.1111/irv.70300. The central investigation, as stated in the title, examines the influence of the ABO blood system on both immunogenicity and vaccine efficacy following a COVID-19 booster vaccination in a cohort of 3,066 participants.
The PubMed page lists multiple authors with primary affiliations at the Medical University of Vienna, including departments of Internal Medicine III (Division of Rheumatology), Laboratory Medicine, Clinical Pharmacology, Physical Medicine, Rehabilitation and Occupational Medicine, and the Center of Pathophysiology, Infectiology and Immunology. Additional contributors are affiliated with Vismederi srl (Siena, Italy) and the University of Siena. The Arbeiter-Samariter-Bund Wien is also named among affiliations, indicating involvement of an organizational partner in the study.
Author names and linked affiliations are presented on the PubMed record. The collaboration spans clinical, laboratory, pharmacology, and diagnostic assay expertise, consistent with studies that assess vaccine-induced immune responses.
Citation details available on the source page:
The PubMed entry includes usual navigation links (Abstract, Figures, References, Conflict of Interest statement) and full-text linking options (including a Wiley full-text link), but the supplied excerpt does not include the article abstract or full-text content.
The title declares a population-based study of 3,066 individuals, with the research question centered on whether ABO blood group is associated with differences in immune response and measured vaccine efficacy after a COVID-19 booster dose. No further demographic, geographic, inclusion/exclusion, or vaccine-type details are present in the provided source excerpt.
The PubMed excerpt does not contain the abstract text or methods section. Specifics about study design (prospective versus retrospective), sampling frame, timing of booster doses, vaccine platforms studied, laboratory assays used to assess immunogenicity (for example, binding antibody titers, neutralization assays, or cellular immune measures), or definitions of vaccine efficacy (clinical endpoints, infection surveillance, or serologic correlates) are not reported in the supplied content.
Where the PubMed page includes links to the full text, the excerpt does not reproduce the methodological detail. Therefore, methodological parameters and analysis plans cannot be summarized from this source alone.
The provided PubMed page excerpt does not present study results, numerical data, statistical outputs, or author conclusions. No findings regarding associations between ABO blood groups and postbooster immunogenicity or vaccine efficacy are included in the available text. Any statements about effect size, significance, subgroup findings, or clinical outcomes are absent from the supplied source content.
From the excerpt available on PubMed, the following critical information is missing and could not be inferred:
Because these elements are not present in the excerpted PubMed content, readers must consult the complete article to obtain reliable data and conclusions.
The title emphasizes a clinically relevant question—whether an individual’s ABO blood group affects the immune response to a COVID-19 booster and the vaccine’s protective effectiveness. If supported by rigorous data, such findings could inform risk stratification, personalized counseling, or mechanistic research into blood-group–mediated immunologic differences.
However, the PubMed excerpt contains no results or conclusions; therefore, no clinical actions or practice changes can be recommended based on this record alone. Clinicians and researchers should retrieve and appraise the full text for validated outcome measures, effect sizes, and study limitations before applying findings to practice or further research.
The PubMed record provides a link to full-text options (including a Wiley link) and indicates standard article sections (Abstract, Figures, References, Conflict of Interest statement) that are not included in the supplied excerpt. To evaluate the study’s methods and results, obtain numeric data, and judge the validity and applicability of conclusions, consult the full-text article via the journal publisher or institutional access.
For literature searches or citation tracking, use the DOI 10.1111/irv.70300 or PubMed PMID 42524760. Any summary beyond the bibliographic and title-level information presented here would require direct extraction from the full article; such details were not reported in the source excerpt provided.